Eller Lucille Sanzero, Lev Elise L, Gejerman Glen, Colella Joan, Esposito Michael, Lanteri Vincent, Scheuch John, Munver Ravi, Lane Patricia, Junchaya Claudia, Alves Laura, Galli Bernadette, Watson Richard, Sawczuk Ihor
College of Nursing, Rutgers, The State University of New Jersey, 180 University Avenue, Newark, NJ 07102, USA.
Nurs Res. 2006 Mar-Apr;55(2 Suppl):S28-36.
No research was found that compared quality of life (QOL) outcomes of prostate cancer patients receiving intensity-modulated radiation therapies with prostate cancer patients receiving radical prostatectomy.
To (a) describe differences in QOL before and after three types of treatment for prostate cancer: radical prostatectomy, intensity-modulated radiation therapy + seed implantation (permanent brachytherapy), or intensity-modulated radiation therapy + high dose rate radiotherapy (temporary brachytherapy); and (b) investigate demographic, physical, and psychosocial variables that impact QOL of men with prostate cancer.
Data were collected on three occasions: baseline (prior to treatment), 1 month, and 3 months after beginning treatment. Measures included biographic data, physiological, and psychological measures. Analysis of variance and hierarchical regression were used to examine patterns, describe differences, and identify predictors of QOL in the three treatment groups. QOL was conceptualized as a multidimensional construct that included physical, psychological, social, and functional well-being and prostate cancer concerns.
Groups differed significantly in bowel and urinary symptom scores and prostate cancer concerns at baseline, and in urinary and depressive symptoms at 3 months. There were no significant group differences at 1 month.
Significant differences were found in QOL as measured with the Functional Assessment of Cancer Treatment-Prostate after treatment with radical prostatectomy, intensity-modulated radiation therapy + seed implantation, or intensity-modulated radiation therapy + high dose rate radiotherapy. Findings may provide healthcare providers with knowledge about treatment sequelae for prostate cancer, enable healthcare providers to educate patients about QOL outcomes of treatment for prostate cancer, and enable patients to make more informed treatment decisions.
未发现有研究对接受调强放射治疗的前列腺癌患者与接受根治性前列腺切除术的前列腺癌患者的生活质量(QOL)结果进行比较。
(a)描述前列腺癌三种治疗方法(根治性前列腺切除术、调强放射治疗+粒子植入术(永久性近距离放射治疗)或调强放射治疗+高剂量率放射治疗(临时性近距离放射治疗))前后生活质量的差异;(b)调查影响前列腺癌男性患者生活质量的人口统计学、身体和心理社会变量。
在三个时间点收集数据:基线(治疗前)、开始治疗后1个月和3个月。测量指标包括传记数据、生理和心理指标。采用方差分析和层次回归来检查模式、描述差异并确定三个治疗组生活质量的预测因素。生活质量被概念化为一个多维结构,包括身体、心理、社会和功能健康以及对前列腺癌的担忧。
各组在基线时的肠道和泌尿系统症状评分以及对前列腺癌的担忧方面存在显著差异,在3个月时的泌尿系统和抑郁症状方面也存在显著差异。1个月时各组之间无显著差异。
在用根治性前列腺切除术、调强放射治疗+粒子植入术或调强放射治疗+高剂量率放射治疗后,使用癌症治疗功能评估-前列腺量表测量的生活质量存在显著差异。研究结果可为医疗保健提供者提供有关前列腺癌治疗后遗症的知识,使医疗保健提供者能够就前列腺癌治疗的生活质量结果对患者进行教育,并使患者能够做出更明智的治疗决策。